Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Generate Biomedicines, Inc. is a clinical-stage generative biology company focusing on the Artificial intelligence (AI) revolution in biotechnology and drug design and development. The Company is engaged in the field of generative biology using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its Generate Platform integrates generative and predictive models that learn design principles from proprietary data and graph neural networks, among other architectures. Its lead product candidate, GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma. Its other product candidates include GB-4362, a systemically administered monoclonal antibody designed to neutralize free monomethyl auristatin E (MMAE) as an adjunctive therapy to antibody-drug conjugate (ADC) molecules with an MMAE payload, as well as GB-5267, an armored, MUC16-directed CAR-T cell therapy candidate.
Find out what a historical investment in Generate Biomedicines would be worth today using our GENB stock calculator.
Buying GENB shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Generate Biomedicines in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in GENB
What is the ticker symbol of Generate Biomedicines?
The ticker symbol for Generate Biomedicines is GENB.
How much is one share of GENB?
One share of GENB is valued at $10.37 as of 20 November 2026.
What is the market capitalisation of Generate Biomedicines GENB?
As of 20 November 2026 Generate Biomedicines has a market cap of $1.34B.
What is the 52-week high for Generate Biomedicines stock?
The Generate Biomedicines 52-week high stock price is $22.67.
What is the 52-week low for Generate Biomedicines stock?
The Generate Biomedicines 52-week low stock price is $9.68.
Can I buy GENB shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy GENB shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GENB on Stake
Buy GENB from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of GENB from only US$10 with fractional shares